Imiquimod in the treatment of extensive recurrent lentigo maligna - 21/08/11
Doi : 10.1016/j.jaad.2004.07.047
Anne Kamin, MD, Thomas K. Eigentler, MD, Peter Radny, MD, Jürgen Bauer, MD, Benjamin Weide, MD, Claus Garbe, PhD ⁎ 
From the Department of Dermatology, Skin Cancer Program, Eberhard Karls University
Reprint requests: Claus Garbe, MD, Professor of Dermatology, Department of Dermatology, Eberhard-Karls-University, Liebermeisterstrasse 25, 72076 Tuebingen, Germany.Tuebingen, Germany
Résumé |
We report the case of a 70-year-old white male with an extensive recurrence of lentigo maligna in a skin-transplanted region. He was treated with imiquimod 5% cream topically applied 5 times a week for a total duration of 9 months. Clinically and histologically, a complete clearing of the lesion was observed after treatment. Topical treatment with imiquimod seems to be effective and safe in lentigo maligna.
Le texte complet de cet article est disponible en PDF.| This supplement is made possible through the generous support of Stiefel Laboratories for the American Academy of Dermatology. Funding sources: None. Conflicts of interest: None identified. |
© 2005
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 52 - N° 2S
P. S51-S52 - février 2005 Retour au numéro
Article précédent
- A case of Spitz nevus with multiple satellite lesions
- Ji Youn Song, Ji Ae Kwon, Chul Jong Park
- Silicone granuloma of the face treated with minocycline
- Meral J. Arin, Jens Bäte, Thomas Krieg, Nicolas Hunzelmann
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?